To investigate the incremental prognostic value of the cholesterol profile, a reduced model was also constructed (ModelCLL-IPI), which consisted of five parameters in CLL-IPI: age, stage, β2-MG level, TP53, and IGHV status. This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.